CHINA TOPIX

11/24/2024 11:14:40 pm

Make CT Your Homepage

Pfizer

Welcome, Pfizer

Pfizer to Build Global Biotechnology Center in Hangzhou, China

The Hangzhou facility will be Pfizer's third biotechnology center globally and the first in Asia.

Pfizer

Pfizer to Invest $350 Million in its First Global Biotechnology Center in Asia, new Facility in China's Hangzhou Region

The U.S. pharmaceutical giant Pfizer will set up a $350 million biotechnology plant in China's eastern Hangzhou city.

An inhuman way to die

Electric Chair and Firing Squads Making a Comeback in the US; Pfizer says 'No' to Executions

Tennessee in 2014 authorized prison officials to use the electric chair if lethal injection drugs are unavailable.

China Faces Health Risk As Pfizer Pulls Out Vaccine Product

China Faces Health Risk As Pfizer Pulls Out Vaccine Product

China is at a high risk of shortage of treatment for pneumonia after it failed to renew Pfizer's license to market its product, Prevenar.

Pfizer

FDA Changes Warning Label on Anti-Smoking Drug Chantix

The FDA has warned Chantix might cause seizures and other psychiatric side effects

Pfizer Chief Executive Ian Read

Pfizer Abandons $118 Billion Astra Deal

Pfizer Inc. left its investors speculating after cancelling its US$118 billion bid for AstraZeneca on Tuesday.

AstraZeneca

AstraZeneca Acquires Almirall Lung Drugs In US$2.1B Deal

British-Swedish pharmacaeutical giant AstraZeneca acquired the rights to the lung drugs of Spanish firm Almirall in a US$2.1 billion-deal after refusing Pfizer’s takeover offer in May.

Pfizer

Pfizer-AstraZeneca Merger Could Face Hurdles With Chinese Antitrust Authorities

The deal between Pfizer and AstraZeneca could face hurdles in China'a antitrust regulators.

Real Time Analytics